Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,763
archived clinical trials in
Colitis

Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis
A Multicenter, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Evaluate the Long Term Safety and Tolerability of Repeated Administration of Adalimumab in Subjects With Ulcerative Colitis
Status: Enrolling
Updated:  4/26/2017
Clinical Research Facility
mi
from
Charlotte, NC
Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis
A Multicenter, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Evaluate the Long Term Safety and Tolerability of Repeated Administration of Adalimumab in Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 4/26/2017
Clinical Research Facility
mi
from
Charlotte, NC
Click here to add this to my saved trials
Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis
A Multicenter, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Evaluate the Long Term Safety and Tolerability of Repeated Administration of Adalimumab in Subjects With Ulcerative Colitis
Status: Enrolling
Updated:  4/26/2017
Clinical Research Facility
mi
from
Jacksonville, NC
Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis
A Multicenter, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Evaluate the Long Term Safety and Tolerability of Repeated Administration of Adalimumab in Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 4/26/2017
Clinical Research Facility
mi
from
Jacksonville, NC
Click here to add this to my saved trials
Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis
A Multicenter, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Evaluate the Long Term Safety and Tolerability of Repeated Administration of Adalimumab in Subjects With Ulcerative Colitis
Status: Enrolling
Updated:  4/26/2017
Clinical Research Facility
mi
from
Raleigh, NC
Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis
A Multicenter, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Evaluate the Long Term Safety and Tolerability of Repeated Administration of Adalimumab in Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 4/26/2017
Clinical Research Facility
mi
from
Raleigh, NC
Click here to add this to my saved trials
Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis
A Multicenter, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Evaluate the Long Term Safety and Tolerability of Repeated Administration of Adalimumab in Subjects With Ulcerative Colitis
Status: Enrolling
Updated:  4/26/2017
Clinical Research Facility
mi
from
Cincinnati, OH
Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis
A Multicenter, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Evaluate the Long Term Safety and Tolerability of Repeated Administration of Adalimumab in Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 4/26/2017
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis
A Multicenter, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Evaluate the Long Term Safety and Tolerability of Repeated Administration of Adalimumab in Subjects With Ulcerative Colitis
Status: Enrolling
Updated:  4/26/2017
Clinical Research Facility
mi
from
Columbia, SC
Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis
A Multicenter, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Evaluate the Long Term Safety and Tolerability of Repeated Administration of Adalimumab in Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 4/26/2017
Clinical Research Facility
mi
from
Columbia, SC
Click here to add this to my saved trials
Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis
A Multicenter, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Evaluate the Long Term Safety and Tolerability of Repeated Administration of Adalimumab in Subjects With Ulcerative Colitis
Status: Enrolling
Updated:  4/26/2017
Clinical Research Facility
mi
from
Germantown, TN
Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis
A Multicenter, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Evaluate the Long Term Safety and Tolerability of Repeated Administration of Adalimumab in Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 4/26/2017
Clinical Research Facility
mi
from
Germantown, TN
Click here to add this to my saved trials
Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis
A Multicenter, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Evaluate the Long Term Safety and Tolerability of Repeated Administration of Adalimumab in Subjects With Ulcerative Colitis
Status: Enrolling
Updated:  4/26/2017
Clinical Research Facility
mi
from
Nashville, TN
Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis
A Multicenter, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Evaluate the Long Term Safety and Tolerability of Repeated Administration of Adalimumab in Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 4/26/2017
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis
A Multicenter, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Evaluate the Long Term Safety and Tolerability of Repeated Administration of Adalimumab in Subjects With Ulcerative Colitis
Status: Enrolling
Updated:  4/26/2017
Clinical Research Facility
mi
from
Ogden, UT
Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis
A Multicenter, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Evaluate the Long Term Safety and Tolerability of Repeated Administration of Adalimumab in Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 4/26/2017
Clinical Research Facility
mi
from
Ogden, UT
Click here to add this to my saved trials
Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis
A Multicenter, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Evaluate the Long Term Safety and Tolerability of Repeated Administration of Adalimumab in Subjects With Ulcerative Colitis
Status: Enrolling
Updated:  4/26/2017
Clinical Research Facility
mi
from
Bellevue, WA
Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis
A Multicenter, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Evaluate the Long Term Safety and Tolerability of Repeated Administration of Adalimumab in Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 4/26/2017
Clinical Research Facility
mi
from
Bellevue, WA
Click here to add this to my saved trials
Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis
A Multicenter, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Evaluate the Long Term Safety and Tolerability of Repeated Administration of Adalimumab in Subjects With Ulcerative Colitis
Status: Enrolling
Updated:  4/26/2017
Clinical Research Facility
mi
from
Spokane, WA
Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis
A Multicenter, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Evaluate the Long Term Safety and Tolerability of Repeated Administration of Adalimumab in Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 4/26/2017
Clinical Research Facility
mi
from
Spokane, WA
Click here to add this to my saved trials
Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis
A Multicenter, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Evaluate the Long Term Safety and Tolerability of Repeated Administration of Adalimumab in Subjects With Ulcerative Colitis
Status: Enrolling
Updated:  4/26/2017
Clinical Research Facility
mi
from
Milwaukee, WI
Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis
A Multicenter, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Evaluate the Long Term Safety and Tolerability of Repeated Administration of Adalimumab in Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 4/26/2017
Clinical Research Facility
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis
A Multicenter, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Evaluate the Long Term Safety and Tolerability of Repeated Administration of Adalimumab in Subjects With Ulcerative Colitis
Status: Enrolling
Updated:  4/26/2017
Clinical Research Facility
mi
from
West Bend, WI
Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis
A Multicenter, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Evaluate the Long Term Safety and Tolerability of Repeated Administration of Adalimumab in Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 4/26/2017
Clinical Research Facility
mi
from
West Bend, WI
Click here to add this to my saved trials
Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis
A Multicenter, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Evaluate the Long Term Safety and Tolerability of Repeated Administration of Adalimumab in Subjects With Ulcerative Colitis
Status: Enrolling
Updated:  4/26/2017
Site Reference ID/Investigator# 22507
mi
from
Bedford Park,
Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis
A Multicenter, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Evaluate the Long Term Safety and Tolerability of Repeated Administration of Adalimumab in Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 4/26/2017
Site Reference ID/Investigator# 22507
mi
from
Bedford Park,
Click here to add this to my saved trials
Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis
A Multicenter, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Evaluate the Long Term Safety and Tolerability of Repeated Administration of Adalimumab in Subjects With Ulcerative Colitis
Status: Enrolling
Updated:  4/26/2017
Clinical Research Facility
mi
from
Saint Louis, MO
Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis
A Multicenter, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Evaluate the Long Term Safety and Tolerability of Repeated Administration of Adalimumab in Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 4/26/2017
Clinical Research Facility
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Compassionate Use of Nitazoxanide for the Treatment of Clostridium Difficile Infection
Compassionate Use of Nitazoxanide for the Treatment of Clostridium Difficile Colitis in Patients Who Have Failed Conventional Therapy
Status: Enrolling
Updated:  5/8/2017
Baylor College of Medicine
mi
from
Houston, TX
Compassionate Use of Nitazoxanide for the Treatment of Clostridium Difficile Infection
Compassionate Use of Nitazoxanide for the Treatment of Clostridium Difficile Colitis in Patients Who Have Failed Conventional Therapy
Status: Enrolling
Updated: 5/8/2017
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
Compassionate Use of Nitazoxanide for the Treatment of Clostridium Difficile Infection
Compassionate Use of Nitazoxanide for the Treatment of Clostridium Difficile Colitis in Patients Who Have Failed Conventional Therapy
Status: Enrolling
Updated:  5/8/2017
Michael E. Debakey VA Medical Center
mi
from
Houston, TX
Compassionate Use of Nitazoxanide for the Treatment of Clostridium Difficile Infection
Compassionate Use of Nitazoxanide for the Treatment of Clostridium Difficile Colitis in Patients Who Have Failed Conventional Therapy
Status: Enrolling
Updated: 5/8/2017
Michael E. Debakey VA Medical Center
mi
from
Houston, TX
Click here to add this to my saved trials
Addition of Lactobacillus to Metronidazole in Treatment of CDAD
Addition of a Probiotic (Lactobacillus GG) to Metronidazole for the Treatment of Clostridium Difficile Associated Disease
Status: Enrolling
Updated:  5/9/2017
Michael E. DeBakey Veterans Affairs Medical Center
mi
from
Houston, TX
Addition of Lactobacillus to Metronidazole in Treatment of CDAD
Addition of a Probiotic (Lactobacillus GG) to Metronidazole for the Treatment of Clostridium Difficile Associated Disease
Status: Enrolling
Updated: 5/9/2017
Michael E. DeBakey Veterans Affairs Medical Center
mi
from
Houston, TX
Click here to add this to my saved trials
Telemedicine in Patients With Inflammatory Bowel Disease (TELE-IBD)
Telemedicine in Patients With Inflammatory Bowel Disease (TELE-IBD)
Status: Enrolling
Updated:  5/16/2017
University of Maryland
mi
from
Baltimore, MD
Telemedicine in Patients With Inflammatory Bowel Disease (TELE-IBD)
Telemedicine in Patients With Inflammatory Bowel Disease (TELE-IBD)
Status: Enrolling
Updated: 5/16/2017
University of Maryland
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Phase 1b Study to Assess the Safety and Anti-inflammatory Effects of Two Different Doses of SRT2104 in Patients With Ulcerative Colitis
A Phase 1b, Exploratory Study to Assess the Safety, Tolerability, Colonic Tissue Exposure, and Anti-Inflammatory Effects of Two Different Doses of SRT2104 in Subjects With Mild to Moderate Ulcerative Colitis
Status: Enrolling
Updated:  5/31/2017
GSK Investigational Site
mi
from
Anaheim, CA
A Phase 1b Study to Assess the Safety and Anti-inflammatory Effects of Two Different Doses of SRT2104 in Patients With Ulcerative Colitis
A Phase 1b, Exploratory Study to Assess the Safety, Tolerability, Colonic Tissue Exposure, and Anti-Inflammatory Effects of Two Different Doses of SRT2104 in Subjects With Mild to Moderate Ulcerative Colitis
Status: Enrolling
Updated: 5/31/2017
GSK Investigational Site
mi
from
Anaheim, CA
Click here to add this to my saved trials
A Phase 1b Study to Assess the Safety and Anti-inflammatory Effects of Two Different Doses of SRT2104 in Patients With Ulcerative Colitis
A Phase 1b, Exploratory Study to Assess the Safety, Tolerability, Colonic Tissue Exposure, and Anti-Inflammatory Effects of Two Different Doses of SRT2104 in Subjects With Mild to Moderate Ulcerative Colitis
Status: Enrolling
Updated:  5/31/2017
GSK Investigational Site
mi
from
Bristol, CT
A Phase 1b Study to Assess the Safety and Anti-inflammatory Effects of Two Different Doses of SRT2104 in Patients With Ulcerative Colitis
A Phase 1b, Exploratory Study to Assess the Safety, Tolerability, Colonic Tissue Exposure, and Anti-Inflammatory Effects of Two Different Doses of SRT2104 in Subjects With Mild to Moderate Ulcerative Colitis
Status: Enrolling
Updated: 5/31/2017
GSK Investigational Site
mi
from
Bristol, CT
Click here to add this to my saved trials
A Phase 1b Study to Assess the Safety and Anti-inflammatory Effects of Two Different Doses of SRT2104 in Patients With Ulcerative Colitis
A Phase 1b, Exploratory Study to Assess the Safety, Tolerability, Colonic Tissue Exposure, and Anti-Inflammatory Effects of Two Different Doses of SRT2104 in Subjects With Mild to Moderate Ulcerative Colitis
Status: Enrolling
Updated:  5/31/2017
GSK Investigational Site
mi
from
Owensboro, KY
A Phase 1b Study to Assess the Safety and Anti-inflammatory Effects of Two Different Doses of SRT2104 in Patients With Ulcerative Colitis
A Phase 1b, Exploratory Study to Assess the Safety, Tolerability, Colonic Tissue Exposure, and Anti-Inflammatory Effects of Two Different Doses of SRT2104 in Subjects With Mild to Moderate Ulcerative Colitis
Status: Enrolling
Updated: 5/31/2017
GSK Investigational Site
mi
from
Owensboro, KY
Click here to add this to my saved trials
A Phase 1b Study to Assess the Safety and Anti-inflammatory Effects of Two Different Doses of SRT2104 in Patients With Ulcerative Colitis
A Phase 1b, Exploratory Study to Assess the Safety, Tolerability, Colonic Tissue Exposure, and Anti-Inflammatory Effects of Two Different Doses of SRT2104 in Subjects With Mild to Moderate Ulcerative Colitis
Status: Enrolling
Updated:  5/31/2017
GSK Investigational Site
mi
from
Chevy Chase, MD
A Phase 1b Study to Assess the Safety and Anti-inflammatory Effects of Two Different Doses of SRT2104 in Patients With Ulcerative Colitis
A Phase 1b, Exploratory Study to Assess the Safety, Tolerability, Colonic Tissue Exposure, and Anti-Inflammatory Effects of Two Different Doses of SRT2104 in Subjects With Mild to Moderate Ulcerative Colitis
Status: Enrolling
Updated: 5/31/2017
GSK Investigational Site
mi
from
Chevy Chase, MD
Click here to add this to my saved trials
A Phase 1b Study to Assess the Safety and Anti-inflammatory Effects of Two Different Doses of SRT2104 in Patients With Ulcerative Colitis
A Phase 1b, Exploratory Study to Assess the Safety, Tolerability, Colonic Tissue Exposure, and Anti-Inflammatory Effects of Two Different Doses of SRT2104 in Subjects With Mild to Moderate Ulcerative Colitis
Status: Enrolling
Updated:  5/31/2017
GSK Investigational Site
mi
from
Towson, MD
A Phase 1b Study to Assess the Safety and Anti-inflammatory Effects of Two Different Doses of SRT2104 in Patients With Ulcerative Colitis
A Phase 1b, Exploratory Study to Assess the Safety, Tolerability, Colonic Tissue Exposure, and Anti-Inflammatory Effects of Two Different Doses of SRT2104 in Subjects With Mild to Moderate Ulcerative Colitis
Status: Enrolling
Updated: 5/31/2017
GSK Investigational Site
mi
from
Towson, MD
Click here to add this to my saved trials
A Phase 1b Study to Assess the Safety and Anti-inflammatory Effects of Two Different Doses of SRT2104 in Patients With Ulcerative Colitis
A Phase 1b, Exploratory Study to Assess the Safety, Tolerability, Colonic Tissue Exposure, and Anti-Inflammatory Effects of Two Different Doses of SRT2104 in Subjects With Mild to Moderate Ulcerative Colitis
Status: Enrolling
Updated:  5/31/2017
GSK Investigational Site
mi
from
Chesterfield, MI
A Phase 1b Study to Assess the Safety and Anti-inflammatory Effects of Two Different Doses of SRT2104 in Patients With Ulcerative Colitis
A Phase 1b, Exploratory Study to Assess the Safety, Tolerability, Colonic Tissue Exposure, and Anti-Inflammatory Effects of Two Different Doses of SRT2104 in Subjects With Mild to Moderate Ulcerative Colitis
Status: Enrolling
Updated: 5/31/2017
GSK Investigational Site
mi
from
Chesterfield, MI
Click here to add this to my saved trials
A Phase 1b Study to Assess the Safety and Anti-inflammatory Effects of Two Different Doses of SRT2104 in Patients With Ulcerative Colitis
A Phase 1b, Exploratory Study to Assess the Safety, Tolerability, Colonic Tissue Exposure, and Anti-Inflammatory Effects of Two Different Doses of SRT2104 in Subjects With Mild to Moderate Ulcerative Colitis
Status: Enrolling
Updated:  5/31/2017
GSK Investigational Site
mi
from
Great Neck, NY
A Phase 1b Study to Assess the Safety and Anti-inflammatory Effects of Two Different Doses of SRT2104 in Patients With Ulcerative Colitis
A Phase 1b, Exploratory Study to Assess the Safety, Tolerability, Colonic Tissue Exposure, and Anti-Inflammatory Effects of Two Different Doses of SRT2104 in Subjects With Mild to Moderate Ulcerative Colitis
Status: Enrolling
Updated: 5/31/2017
GSK Investigational Site
mi
from
Great Neck, NY
Click here to add this to my saved trials
A Phase 1b Study to Assess the Safety and Anti-inflammatory Effects of Two Different Doses of SRT2104 in Patients With Ulcerative Colitis
A Phase 1b, Exploratory Study to Assess the Safety, Tolerability, Colonic Tissue Exposure, and Anti-Inflammatory Effects of Two Different Doses of SRT2104 in Subjects With Mild to Moderate Ulcerative Colitis
Status: Enrolling
Updated:  5/31/2017
GSK Investigational Site
mi
from
New York, NY
A Phase 1b Study to Assess the Safety and Anti-inflammatory Effects of Two Different Doses of SRT2104 in Patients With Ulcerative Colitis
A Phase 1b, Exploratory Study to Assess the Safety, Tolerability, Colonic Tissue Exposure, and Anti-Inflammatory Effects of Two Different Doses of SRT2104 in Subjects With Mild to Moderate Ulcerative Colitis
Status: Enrolling
Updated: 5/31/2017
GSK Investigational Site
mi
from
New York, NY
Click here to add this to my saved trials
A Phase 1b Study to Assess the Safety and Anti-inflammatory Effects of Two Different Doses of SRT2104 in Patients With Ulcerative Colitis
A Phase 1b, Exploratory Study to Assess the Safety, Tolerability, Colonic Tissue Exposure, and Anti-Inflammatory Effects of Two Different Doses of SRT2104 in Subjects With Mild to Moderate Ulcerative Colitis
Status: Enrolling
Updated:  5/31/2017
GSK Investigational Site
mi
from
Raleigh, NC
A Phase 1b Study to Assess the Safety and Anti-inflammatory Effects of Two Different Doses of SRT2104 in Patients With Ulcerative Colitis
A Phase 1b, Exploratory Study to Assess the Safety, Tolerability, Colonic Tissue Exposure, and Anti-Inflammatory Effects of Two Different Doses of SRT2104 in Subjects With Mild to Moderate Ulcerative Colitis
Status: Enrolling
Updated: 5/31/2017
GSK Investigational Site
mi
from
Raleigh, NC
Click here to add this to my saved trials
A Phase 1b Study to Assess the Safety and Anti-inflammatory Effects of Two Different Doses of SRT2104 in Patients With Ulcerative Colitis
A Phase 1b, Exploratory Study to Assess the Safety, Tolerability, Colonic Tissue Exposure, and Anti-Inflammatory Effects of Two Different Doses of SRT2104 in Subjects With Mild to Moderate Ulcerative Colitis
Status: Enrolling
Updated:  5/31/2017
GSK Investigational Site
mi
from
Beavercreek, OH
A Phase 1b Study to Assess the Safety and Anti-inflammatory Effects of Two Different Doses of SRT2104 in Patients With Ulcerative Colitis
A Phase 1b, Exploratory Study to Assess the Safety, Tolerability, Colonic Tissue Exposure, and Anti-Inflammatory Effects of Two Different Doses of SRT2104 in Subjects With Mild to Moderate Ulcerative Colitis
Status: Enrolling
Updated: 5/31/2017
GSK Investigational Site
mi
from
Beavercreek, OH
Click here to add this to my saved trials
A Phase 1b Study to Assess the Safety and Anti-inflammatory Effects of Two Different Doses of SRT2104 in Patients With Ulcerative Colitis
A Phase 1b, Exploratory Study to Assess the Safety, Tolerability, Colonic Tissue Exposure, and Anti-Inflammatory Effects of Two Different Doses of SRT2104 in Subjects With Mild to Moderate Ulcerative Colitis
Status: Enrolling
Updated:  5/31/2017
GSK Investigational Site
mi
from
Columbus, OH
A Phase 1b Study to Assess the Safety and Anti-inflammatory Effects of Two Different Doses of SRT2104 in Patients With Ulcerative Colitis
A Phase 1b, Exploratory Study to Assess the Safety, Tolerability, Colonic Tissue Exposure, and Anti-Inflammatory Effects of Two Different Doses of SRT2104 in Subjects With Mild to Moderate Ulcerative Colitis
Status: Enrolling
Updated: 5/31/2017
GSK Investigational Site
mi
from
Columbus, OH
Click here to add this to my saved trials
A Phase 1b Study to Assess the Safety and Anti-inflammatory Effects of Two Different Doses of SRT2104 in Patients With Ulcerative Colitis
A Phase 1b, Exploratory Study to Assess the Safety, Tolerability, Colonic Tissue Exposure, and Anti-Inflammatory Effects of Two Different Doses of SRT2104 in Subjects With Mild to Moderate Ulcerative Colitis
Status: Enrolling
Updated:  5/31/2017
GSK Investigational Site
mi
from
Oklahoma City, OK
A Phase 1b Study to Assess the Safety and Anti-inflammatory Effects of Two Different Doses of SRT2104 in Patients With Ulcerative Colitis
A Phase 1b, Exploratory Study to Assess the Safety, Tolerability, Colonic Tissue Exposure, and Anti-Inflammatory Effects of Two Different Doses of SRT2104 in Subjects With Mild to Moderate Ulcerative Colitis
Status: Enrolling
Updated: 5/31/2017
GSK Investigational Site
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
A Phase 1b Study to Assess the Safety and Anti-inflammatory Effects of Two Different Doses of SRT2104 in Patients With Ulcerative Colitis
A Phase 1b, Exploratory Study to Assess the Safety, Tolerability, Colonic Tissue Exposure, and Anti-Inflammatory Effects of Two Different Doses of SRT2104 in Subjects With Mild to Moderate Ulcerative Colitis
Status: Enrolling
Updated:  5/31/2017
GSK Investigational Site
mi
from
Jackson, TN
A Phase 1b Study to Assess the Safety and Anti-inflammatory Effects of Two Different Doses of SRT2104 in Patients With Ulcerative Colitis
A Phase 1b, Exploratory Study to Assess the Safety, Tolerability, Colonic Tissue Exposure, and Anti-Inflammatory Effects of Two Different Doses of SRT2104 in Subjects With Mild to Moderate Ulcerative Colitis
Status: Enrolling
Updated: 5/31/2017
GSK Investigational Site
mi
from
Jackson, TN
Click here to add this to my saved trials
Clotrimazole Enemas for Pouchitis in Children and Adults
Clotrimazole Enemas for Pouchitis in Children and Adults
Status: Enrolling
Updated:  7/18/2017
Boston Children's Hospital
mi
from
Boston, MA
Clotrimazole Enemas for Pouchitis in Children and Adults
Clotrimazole Enemas for Pouchitis in Children and Adults
Status: Enrolling
Updated: 7/18/2017
Boston Children's Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Self-Management Assistance for Recommended Treatment (SMART) Portal
Self-Management Assistance for Recommended Treatment (SMART) Portal
Status: Enrolling
Updated:  7/18/2017
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Self-Management Assistance for Recommended Treatment (SMART) Portal
Self-Management Assistance for Recommended Treatment (SMART) Portal
Status: Enrolling
Updated: 7/18/2017
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Self-Management Assistance for Recommended Treatment (SMART) Portal
Self-Management Assistance for Recommended Treatment (SMART) Portal
Status: Enrolling
Updated:  7/18/2017
BeHealth Solutions, LLC
mi
from
Charlottesville, VA
Self-Management Assistance for Recommended Treatment (SMART) Portal
Self-Management Assistance for Recommended Treatment (SMART) Portal
Status: Enrolling
Updated: 7/18/2017
BeHealth Solutions, LLC
mi
from
Charlottesville, VA
Click here to add this to my saved trials
A Multi-strain Synbiotic Versus a Multi-strain Probiotic in Premature Infants
A Randomized Controlled Trial on a Multi-strain Synbiotic vs. a Multi-strain Probiotic on Fecal Colonization in the Very Low Birth Weight Infant
Status: Enrolling
Updated:  9/12/2017
Nebraska Medical Center
mi
from
Omaha, NE
A Multi-strain Synbiotic Versus a Multi-strain Probiotic in Premature Infants
A Randomized Controlled Trial on a Multi-strain Synbiotic vs. a Multi-strain Probiotic on Fecal Colonization in the Very Low Birth Weight Infant
Status: Enrolling
Updated: 9/12/2017
Nebraska Medical Center
mi
from
Omaha, NE
Click here to add this to my saved trials
Characteristics of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort
Demographics, Clinical Characteristics, and Pathology of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort
Status: Enrolling
Updated:  10/20/2017
University of Arkansas for Medical Science
mi
from
Little Rock, AR
Characteristics of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort
Demographics, Clinical Characteristics, and Pathology of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort
Status: Enrolling
Updated: 10/20/2017
University of Arkansas for Medical Science
mi
from
Little Rock, AR
Click here to add this to my saved trials
Characteristics of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort
Demographics, Clinical Characteristics, and Pathology of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort
Status: Enrolling
Updated:  10/20/2017
Childrens Hospital Colorado
mi
from
Denver, CO
Characteristics of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort
Demographics, Clinical Characteristics, and Pathology of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort
Status: Enrolling
Updated: 10/20/2017
Childrens Hospital Colorado
mi
from
Denver, CO
Click here to add this to my saved trials
Characteristics of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort
Demographics, Clinical Characteristics, and Pathology of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort
Status: Enrolling
Updated:  10/20/2017
Northwestern University
mi
from
Chicago, IL
Characteristics of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort
Demographics, Clinical Characteristics, and Pathology of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort
Status: Enrolling
Updated: 10/20/2017
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
Characteristics of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort
Demographics, Clinical Characteristics, and Pathology of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort
Status: Enrolling
Updated:  10/20/2017
Ann & Robert H. Lurie Children's Hospital of Chicago
mi
from
Chicago, IL
Characteristics of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort
Demographics, Clinical Characteristics, and Pathology of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort
Status: Enrolling
Updated: 10/20/2017
Ann & Robert H. Lurie Children's Hospital of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Characteristics of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort
Demographics, Clinical Characteristics, and Pathology of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort
Status: Enrolling
Updated:  10/20/2017
Tufts University School of Medicine
mi
from
Boston, MA
Characteristics of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort
Demographics, Clinical Characteristics, and Pathology of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort
Status: Enrolling
Updated: 10/20/2017
Tufts University School of Medicine
mi
from
Boston, MA
Click here to add this to my saved trials
Characteristics of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort
Demographics, Clinical Characteristics, and Pathology of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort
Status: Enrolling
Updated:  10/20/2017
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Characteristics of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort
Demographics, Clinical Characteristics, and Pathology of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort
Status: Enrolling
Updated: 10/20/2017
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Characteristics of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort
Demographics, Clinical Characteristics, and Pathology of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort
Status: Enrolling
Updated:  10/20/2017
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Characteristics of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort
Demographics, Clinical Characteristics, and Pathology of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort
Status: Enrolling
Updated: 10/20/2017
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Characteristics of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort
Demographics, Clinical Characteristics, and Pathology of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort
Status: Enrolling
Updated:  10/20/2017
Univ of Pennsylvania
mi
from
Philadelphia, PA
Characteristics of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort
Demographics, Clinical Characteristics, and Pathology of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort
Status: Enrolling
Updated: 10/20/2017
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Pilot Study of Green Tea Extract (Polyphenon E®)in Ulcerative Colitis
A Phase IIa Pilot Study to Determine the Safety of an Oral Dose of Green Tea Extract (Polyphenon E®) and Provide Preliminary Evidence to Support Its Efficacy in Ulcerative Colitis
Status: Enrolling
Updated:  11/14/2017
University of Louisville Clinical Research Center
mi
from
Louisville, KY
Pilot Study of Green Tea Extract (Polyphenon E®)in Ulcerative Colitis
A Phase IIa Pilot Study to Determine the Safety of an Oral Dose of Green Tea Extract (Polyphenon E®) and Provide Preliminary Evidence to Support Its Efficacy in Ulcerative Colitis
Status: Enrolling
Updated: 11/14/2017
University of Louisville Clinical Research Center
mi
from
Louisville, KY
Click here to add this to my saved trials
AMG 181 Phase 2 Study in Subjects With Moderate to Severe Ulcerative Colitis
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Birmingham, AL
AMG 181 Phase 2 Study in Subjects With Moderate to Severe Ulcerative Colitis
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
AMG 181 Phase 2 Study in Subjects With Moderate to Severe Ulcerative Colitis
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Dothan, AL
AMG 181 Phase 2 Study in Subjects With Moderate to Severe Ulcerative Colitis
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Dothan, AL
Click here to add this to my saved trials
AMG 181 Phase 2 Study in Subjects With Moderate to Severe Ulcerative Colitis
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Mobile, AL
AMG 181 Phase 2 Study in Subjects With Moderate to Severe Ulcerative Colitis
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Mobile, AL
Click here to add this to my saved trials
AMG 181 Phase 2 Study in Subjects With Moderate to Severe Ulcerative Colitis
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Scottsdale, AZ
AMG 181 Phase 2 Study in Subjects With Moderate to Severe Ulcerative Colitis
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
AMG 181 Phase 2 Study in Subjects With Moderate to Severe Ulcerative Colitis
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
La Jolla, CA
AMG 181 Phase 2 Study in Subjects With Moderate to Severe Ulcerative Colitis
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
La Jolla, CA
Click here to add this to my saved trials
AMG 181 Phase 2 Study in Subjects With Moderate to Severe Ulcerative Colitis
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Torrance, CA
AMG 181 Phase 2 Study in Subjects With Moderate to Severe Ulcerative Colitis
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Torrance, CA
Click here to add this to my saved trials